CSI Market
Sign In | Register

Silence Therapeutics Plc (SLN) Annual Balance Sheets

Annual · GAAP · USD millions
Access SLN quarterly Balance Sheets →
The data below summarizes Silence Therapeutics Plc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SLN/balance-sheets
https://api.csimarket.com/api/v1/companies/SLN/fundamentals
https://api.csimarket.com/api/v1/companies/SLN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent11.28
Cash And Cash Equivalents0.00
Short-term Investments, Total73.84
Current Tax Assets Current0.00
Cash & Short-term Investments84.00
Accounts receivable0.00
Other Noncurrent Assets2.61
Other Current Assets33.54
Total Current Assets118.66
Equipment/Property/Plant Net1.58
Goodwill net10.62
Intangible Assets0.29
Financial Instruments0.00
Tax Assets, Noncurrent80.41
Other Assets, Noncurrent0.29
Other Current Assets-
Current Financial Assets At Amortised Cost-
Other Intangible Assets-
Noncurrent Financial Assets At Amortised Cost-
Noncurrent Assets-
Other Intangible Assets-
Noncurrent Financial Assets At Amortised Cost-
Noncurrent Financial Assets At Amortised Cost-
Noncurrent Assets-
Noncurrent Assets-
Total Assets131.44
Liabilities
Accounts Payable, Other, Current13.36
Accrued Liabilities, Current2.96
Taxes Payable0.04
Total Current Liabilities13.61
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.10
Other liabilities, Noncurrent0.00
Total Liabilities69.14
Stockholders' Equity
Common Stock Value10.29
Additional Paid In Capital Common Stock617.56
Retained Earnings / Accumulated Deficit-562.57
Accumulated Other Comprehensive Income-2.98
Other Equity-2.98
Common Stockholder's Equity-62.30
Total Stockholder's Equity62.30
Liabilities & Stockholder's Equity131.44
4 historic quarters locked

Sign in to unlock the full Silence Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Silence Therapeutics Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 5, 2026
  • Source: sln-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-092591

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI